Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome

被引:67
作者
Carraro, M
Caridi, G
Bruschi, M
Artero, M
Bertelli, R
Zennaro, C
Musante, L
Candiano, G
Perfumo, F
Ghiggeri, GM
机构
[1] Ist Giannina Gaslini, Lab Fisiopatol Uremia, I-16148 Genoa, Italy
[2] Ist Giannina Gaslini, UO Nefrol, I-16148 Genoa, Italy
[3] Univ Trieste, Ist Clin Med, Trieste, Italy
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 07期
关键词
D O I
10.1097/01.ASN.0000016445.29513.AB
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A plasma factor displaying permeability activity in vitro and possibly determining proteinuria has been hypothesized in idiopathic focal segmental glomerulosclerosis (FSGS). In vitro permeability activity (P-alb) was determined in sera of five patients with autosomal recessive steroid-resistant nephrotic syndrome (NPHS2), an inherited condition indistinguishable from idiopathic FSGS oil clinical,rounds, but in which proteinuria is determined by homozygous Mutations of podocin, a key component of the glomerular podocyte. All patients had presented intractable proteinuria with nephrotic syndrome; four developed renal failure and received a renal allograft. For comparison, sera from 31 children with nephrotic syndrome were tested. Pretransplant P-alb was high in all cases (mean 0.81+/-0.06). equivalent to levels observed in idiopathic FSGS. Overall, P-alb did not correlate with proteinuria. The posttransplant outcome was complicated in two patients by recurrence of proteinuria after 10 and 300 d, respectively, that responded to plasmapheresis plus cyclophosphamide. P-alb levels were high at the time of the recurrence episodes and steadily decreased after plasmapheresis, to reach normal levels in the absence of proteinuria after the seventh cycle. In an attempt to explain high P-alb in these patients, putative inhibitors of the permeability activity were Studied. Coincubation of serum with homologous nephrotic urine reduced P-alb to 0, whereas normal urine did not determine any change, which suggests loss of inhibitory substances in nephrotic Urine. The urinary levels of the serum P-alb inhibitors apo J and apo E were negligible in all cases, thus suggesting that other urinary inhibitors were responsible for the neutralizing effect. These data indicate that P-alb is high in NPHS2, probably resulting from loss of inhibitors ill urine. Lack of correlation of P-alb with proteinuria suggests a selective loss of inhibitors. As in idiopathic FSGS, proteinuria may also recur after renal transplantation in NPHS2 patients, and post-transplant proteinuria is associated with high P-alb. The relationship between elevated P-alb and proteinuria in NPHS2 remains to be determined.
引用
收藏
页码:1946 / 1952
页数:7
相关论文
共 20 条
  • [1] RECURRENT FOCAL GLOMERULOSCLEROSIS - NATURAL-HISTORY AND RESPONSE TO THERAPY
    ARTERO, M
    BIAVA, C
    AMEND, W
    TOMLANOVICH, S
    VINCENTI, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 1992, 92 (04) : 375 - 383
  • [2] PLASMAPHERESIS REDUCES PROTEINURIA AND SERUM CAPACITY TO INJURE GLOMERULI IN PATIENTS WITH RECURRENT FOCAL GLOMERULOSCLEROSIS
    ARTERO, ML
    SHARMA, R
    SAVIN, VJ
    VINCENTI, F
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (04) : 574 - 581
  • [3] Apolipoprotein E ε 4 allele and nephrotic glomerular diseases in children
    Asami, T
    Ciomartan, T
    Hayakawa, H
    Uchiyama, M
    Tomisawa, S
    [J]. PEDIATRIC NEPHROLOGY, 1999, 13 (03) : 233 - 236
  • [4] Boute N, 2000, NAT GENET, V25, P125
  • [5] NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome
    Boute, N
    Gribouval, O
    Roselli, S
    Benessy, F
    Lee, H
    Fuchshuber, A
    Dahan, K
    Gubler, MC
    Niaudet, P
    Antignac, C
    [J]. NATURE GENETICS, 2000, 24 (04) : 349 - 354
  • [6] Functional and structural properties of lipid-associated apolipoprotein J (clusterin)
    Calero, M
    Tokuda, T
    Rostagno, A
    Kumar, A
    Zlokovic, B
    Frangione, B
    Ghiso, J
    [J]. BIOCHEMICAL JOURNAL, 1999, 344 : 375 - 383
  • [7] Candiano G, 2001, J AM SOC NEPHROL, V12, P143, DOI 10.1681/ASN.V121143
  • [8] Caridi G, 2001, J AM SOC NEPHROL, V12, P2742, DOI 10.1681/ASN.V12122742
  • [9] RECURRENT NEPHROTIC SYNDROME AFTER TRANSPLANTATION - EARLY TREATMENT WITH PLASMAPHAERESIS AND CYCLOPHOSPHAMIDE
    COCHAT, P
    KASSIR, A
    COLON, S
    GLASTRE, C
    TOURNIAIRE, B
    PARCHOUX, B
    MARTIN, X
    DAVID, L
    [J]. PEDIATRIC NEPHROLOGY, 1993, 7 (01) : 50 - 54
  • [10] Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children
    Dall'Amico, R
    Ghiggeri, G
    Carraro, M
    Artero, M
    Ghio, L
    Zamorani, E
    Zennaro, C
    Basile, G
    Montini, G
    Rivabella, L
    Cardillo, M
    Scalamogna, M
    Ginevri, F
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) : 1048 - 1055